Navigation Links
Penguin Computing Announces Niveus HTX Personal Supercomputer
Date:11/18/2008

Penguin Niveus HTX is based on NVIDIA Tesla GPU Computing technology and integrates dual Intel Quad-Core processors, Solid State drives, and state of the art packaging and cooling in a wall-pluggable unit.

San Francisco, CA (PRWEB) November 18, 2008 -- Penguin Computing has announced the new flagship of its personal supercomputing and technical workstation line, the Niveus HTX, code-named "Bumble Bee." The machine, priced from around $10,000, incorporates NVIDIA Tesla GPU Computing technology and delivers cluster level computing performance from up to 720 GPU cores provided by the Tesla units.
   
The Niveus HTX also incorporates other unique features and capabilities to support High Performance Computing workloads. Among them are dual Intel 3.0 GHz Quad-Core processors (with optional liquid cooling and overclocking), support for up to 32GB RAM, Intel Solid State Drives, and advanced cooling and power management technology to provide quiet operation from standard wall power.

"Now, anyone can have their own supercomputer," says Charles Wuischpard, CEO Penguin Computing, "Technology has reached the point where we can provide up to 3 TFLOPS of compute performance in an office environment for around $10,000. The Niveus HTX leverages NVIDIA Tesla GPU Computing technology and incorporates a number of other advances that make this a uniquely powerful and attractive offering for scientific applications."

"The Penguin Niveus HTX Personal Supercomputer delivers cluster level performance to the desktop at a price point accessible to all computational researchers," said Andrew Walsh, general manager, personal supercomputing at NVIDIA.

Penguin Computing is also refreshing their entire line Technical Workstations to provide a wide range of compute options based on the latest technologies available including one model that will support up to 64GB of RAM for memory intensive applications. For more information, please visit Penguin Computing at (www.insertlandingpagelink.com) or call 1-888-Penguin.

About Penguin Computing:
Penguin Computing, headquartered in San Francisco, California, specializes in complete, integrated HPC clustering solutions. Penguin has been a successful innovator for over a decade, providing Linux HPC solutions to a variety of industries. Penguin's staff, including the originator of the Beowulf Cluster architecture, has unsurpassed experience in delivering a powerful combination of fully integrated HPC clusters, comprehensive cluster management software, and services. For more information about Penguin Computing and Penguin products, or to download Scyld ClusterWare 4.2 for the free 45-day evaluation, please go to www.penguincomputing.com.

Penguin Computing is a registered trademark, and Scyld ClusterWare is a trademark of Penguin Computing, Inc. Linux is a registered trademark of Linus Torvalds. Other names are for informational purposes only and may be trademarks of their respective owners.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1631144.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Yale scientists make 2 giant steps in advancement of quantum computing
2. The future of computing -- carbon nanotubes and superconductors to replace the silicon chip
3. Quantum computing breakthrough arises from unknown molecule
4. REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008
5. University of Pennsylvania scientists move optical computing closer to reality
6. First tunable, noiseless amplifier may boost quantum computing, communications
7. Memoirs of a qubit: Hybrid memory solves key problem for quantum computing
8. FSU scientific computing department hosts international conference
9. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... presented demonstrating the role of the Breast Cancer ... stage, ER+ breast cancer are most at-risk for ... therapy. Data include results from three studies advancing ... provide information related to tumor biology and inform ...
(Date:12/8/2016)... 8, 2016 Oxford ... erweitert seine Palette an anpassbaren SureSeq™ NGS-Panels mit ... Panels, das ein schnelles und kostengünstiges Studium der ... bietet eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, ... einzigen kleinen Panel und ermöglicht eine individuelle Anpassung ...
(Date:12/8/2016)... CA (PRWEB) , ... December 08, 2016 , ... ... as finalists in the World Technology Awards. uBiome is one of just six ... across all categories. , In addition to uBiome, companies nominated as finalists in ...
(Date:12/8/2016)... Dec. 8, 2016 Savannah River Remediation ... and selected NewTechBio,s NT-MAX Lake & Pond ... beneficial bacteria, in conjunction with Hexa Armor/ Rhombo ... with National Pollutant Discharge Elimination System requirements. ... a steady history of elevated pH levels, above ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
Breaking Biology News(10 mins):